Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Buy

Debt to Equity Rating

Buy

Price to Earnings Rating

Neutral

Analyst Rating

Buy

Simple Moving Average

Strong Buy

Exponential Moving Average

Strong Buy

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Neutral

Wall Street Data Solutions Rating

Buy

A

Gildan Activewear Inc. (GIL)

http://www.gildan.com

Gildan is a vertically integrated designer and manufacturer of basic apparel, including T-shirts, underwear, socks, and hosiery. Its primary market is the sale of blank T-shirts, sweatshirts, and other apparel to wholesalers, major clothing brands, and printers (printwear). Gildan also sells branded clothing through retail and direct-to-consumer channels. Brands include Gildan, American Apparel, Comfort Colors, and Gold Toe. Gildan produces most of its clothing at factories in Latin America and recently began operating a new plant in Bangladesh. Incorporated in 1984, the Montreal-based company operates internationally but generates nearly 90% of its sales in the U.S.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/17/1998

Market Cap

6,846,694,050

Shares Outstanding

172,200,000

Weighted SO

172,199,799

Total Employees

N/A

Upcoming Earnings

11/07/2024

Beta

1.6440

Last Div

0.8200

Range

26.99-42.36

Chg

0.1650

Avg Vol

689300

Mkt Cap

6846694050

Exch

NYSE

Country

CA

Phone

15147352023

DCF Diff

17.7242

DCF

24.4658

Div Yield

0.0186

P/S

2.1348

EV Multiple

12.0838

P/FV

3.8194

Div Yield %

1.8573

P/E

16.9338

PEG

2.4928

Payout

0.3202

Current Ratio

2.3537

Quick Ratio

0.9674

Cash Ratio

0.1127

DSO

68.1635

DIO

178.7909

Op Cycle

246.9544

DPO

74.6694

CCC

172.2850

Gross Margin

0.2933

Op Margin

0.1797

Pretax Margin

0.1528

Net Margin

0.1302

Eff Tax Rate

0.1484

ROA

0.1117

ROE

0.2162

ROCE

0.1962

NI/EBT

0.8523

EBT/EBIT

0.8503

EBIT/Rev

0.1797

Debt Ratio

0.3303

D/E

0.6669

LT Debt/Cap

0.3316

Total Debt/Cap

0.4001

Int Coverage

8.2791

CF/Debt

0.5309

Equity Multi

2.0187

Rec Turnover

5.3548

Pay Turnover

4.8882

Inv Turnover

2.0415

FA Turnover

2.5147

Asset Turnover

0.8578

OCF/Share

3.9032

FCF/Share

2.9613

Cash/Share

0.7710

OCF/Sales

0.2045

FCF/OCF

0.7587

CF Coverage

0.5309

ST Coverage

2.0738

CapEx Coverage

4.1440

Div&CapEx Cov

2.2458

P/BV

3.8194

P/B

3.8194

P/S

2.1348

P/E

16.9338

P/FCF

13.7618

P/OCF

10.7873

P/CF

10.7873

PEG

2.4928

P/S

2.1348

EV Multiple

12.0838

P/FV

3.8194

DPS

0.7820

Latest Headlines (EST)

GlobeNewswire Inc. Jun 05, 22:38 Xilio Therapeutics Announces Closing of $50.0 Million Public Offering The Motley Fool Feb 09, 19:30 3 Fabulous Dividend Stocks to Buy in February GlobeNewswire Inc. Nov 27, 00:30 Personalized Medicines Market to Surpass Valuation of USD 1352.81 Billion by 2031 | SkyQuest Technology Benzinga Nov 27, 00:30 Personalized Medicines Market to Surpass Valuation of USD 1352.81 Billion by 2031 | SkyQuest Technology GlobeNewswire Inc. Nov 17, 15:30 Nurix Therapeutics Presents Preclinical Data from Two Autoimmune and Inflammatory Disease Programs, NX-5948 and GS-6791, at ACR Convergence 2024 The Motley Fool Nov 10, 14:30 3 Spectacular High-Yield Dividend Stocks to Buy in November GlobeNewswire Inc. Sep 30, 23:30 VSAT (Very Small Aperture Terminal) Market to Reach $29.9 Billion, Globally, by 2033 at 12.5% CAGR: Allied Market Research The Motley Fool Sep 12, 22:11 Why Gilead Sciences Stock Thrashed the Market Today GlobeNewswire Inc. Aug 03, 16:36 Merus gibt die Finanzergebnisse für das zweite Quartal 2024 bekannt und informiert über den aktuellen Geschäftsverlauf The Motley Fool Jan 22, 18:08 Why Gilead Sciences Stock Got Mashed on Monday Benzinga Jan 22, 16:34 S&P 500, Dow Extend All-Time Highs: 'It's A Lot Of Fun For Stock Investors While It Lasts,' Wall Street Veteran Says MarketWatch Jan 22, 16:34 Dow closes above 38,000 for first time and S&P 500 scores back-to-back records MarketWatch Jan 22, 15:36 Dow tops 38,000 for first time as S&P 500 aims at back-to-back records MarketWatch Jan 22, 13:30 Dow, S&P 500 attempt to build on records as earnings season ramps up MarketWatch Jan 22, 12:42 Dow, S&P 500 attempt to build on records as earnings season ramps up MarketWatch Jan 22, 10:36 Dow, S&P 500 attempt to build on records as earnings season ramps up MarketWatch Jan 22, 10:04 Gilead’s stock tumbles toward biggest selloff in more than nine years as lung-cancer trial disappoints GlobeNewswire Inc. Jan 21, 20:34 Gildan émet des commentaires concernant la violation par Browning West de la loi antitrust américaine GlobeNewswire Inc. Jan 21, 20:34 Gildan Comments on Violations of US Antitrust Law by Browning West GlobeNewswire Inc. Jan 21, 20:34 Gildan émet des commentaires concernant la violation par Browning West de la loi antitrust américaine

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
0.20 08/22/2024 08/01/2024 08/22/2024 09/16/2024
0.20 05/22/2024 05/01/2024 05/23/2024 06/17/2024
0.20 03/12/2024 02/20/2024 03/13/2024 04/08/2024
0.19 11/21/2023 11/01/2023 11/22/2023 12/18/2023
0.19 08/23/2023 08/03/2023 08/24/2023 09/18/2023
0.19 05/23/2023 05/03/2023 05/24/2023 06/19/2023
0.19 03/13/2023 02/22/2023 03/14/2023 04/10/2023
0.17 11/22/2022 11/03/2022 11/23/2022 12/19/2022
0.17 08/24/2022 08/04/2022 08/25/2022 09/19/2022
0.17 05/25/2022 05/04/2022 05/26/2022 06/20/2022
0.17 03/16/2022 02/23/2022 03/17/2022 04/11/2022
0.15 11/23/2021 11/04/2021 11/24/2021 12/20/2021
0.15 08/25/2021 08/06/2021 08/26/2021 09/20/2021
0.15 05/26/2021 05/06/2021 05/27/2021 06/21/2021
0.15 03/11/2020 02/21/2020 03/12/2020 04/06/2020
0.13 11/13/2019 10/30/2019 11/14/2019 12/09/2019
0.13 08/14/2019 07/31/2019 08/15/2019 09/09/2019
0.13 05/15/2019 05/02/2019 05/16/2019 06/10/2019
0.13 03/06/2019 02/22/2019 03/07/2019 04/01/2019
0.11 11/14/2018 11/01/2018 11/15/2018 12/10/2018
0.11 08/15/2018 08/02/2018 08/16/2018 09/10/2018
0.11 05/16/2018 05/02/2018 05/17/2018 06/11/2018
0.11 03/07/2018 02/22/2018 03/08/2018 04/02/2018
0.09 11/15/2017 11/02/2017 11/16/2017 12/11/2017
0.09 08/15/2017 08/04/2017 08/17/2017 09/11/2017
0.09 05/16/2017 05/04/2017 05/18/2017 06/12/2017
0.09 03/07/2017 02/23/2017 03/09/2017 04/03/2017
0.08 11/16/2016 11/04/2016 11/18/2016 12/12/2016
0.08 08/09/2016 07/27/2016 08/11/2016 09/06/2016
0.08 05/17/2016 05/05/2016 05/19/2016 06/13/2016
0.08 03/08/2016 02/24/2016 03/10/2016 04/04/2016
0.06 11/24/2015 11/13/2015 11/27/2015 12/14/2015
0.06 08/12/2015 07/31/2015 08/14/2015 09/08/2015
0.06 05/22/2015 05/14/2015 05/27/2015 06/22/2015
0.13 02/17/2015 02/05/2015 02/19/2015 03/16/2015
0.13 12/16/2014 12/04/2014 12/18/2014 01/12/2015
0.11 08/12/2014 07/31/2014 08/14/2014 09/08/2014
0.11 05/13/2014 05/02/2014 05/15/2014 06/09/2014
0.11 02/18/2014 02/05/2014 02/20/2014 03/17/2014
0.11 12/10/2013 11/21/2013 12/12/2013 01/06/2014
0.09 08/13/2013 08/01/2013 08/15/2013 09/09/2013
0.09 05/14/2013 05/02/2013 05/16/2013 06/10/2013
0.09 02/19/2013 02/06/2013 02/21/2013 03/18/2013
0.09 12/11/2012 11/29/2012 12/13/2012 01/07/2013
0.08 08/14/2012 08/02/2012 08/16/2012 09/10/2012
0.08 05/15/2012 05/03/2012 05/17/2012 06/11/2012
0.08 02/21/2012 02/10/2012 02/23/2012 03/19/2012
0.08 12/13/2011 12/02/2011 12/15/2011 01/06/2012
0.08 08/16/2011 08/05/2011 08/18/2011 09/09/2011
0.08 05/23/2011 05/12/2011 05/25/2011 06/17/2011
0.08 02/18/2011 12/02/2010 02/23/2011 03/18/2011